tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Aptevo Therapeutics Inc

APVO
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
0.594USD
-0.066-10.00%
์ข…๊ฐ€ย 11-13 16:00๏ผˆET๏ผ‰
1.08M์‹œ๊ฐ€์ด์•ก
0.00P/E TTM

APVO ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Aptevo Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ
์‹œ๊ฐ€์ด์•ก
1.08M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
0.00
์ฃผ๋‹น์ˆœ์ด์ต
1.49K
์ˆ˜์ต
--
์ˆœ์ด์ต
-24.13M
ROE
-550.82%
ROA
-185.92%
Aptevo Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜
์ตœ์‹  ์ถœ์‹œ
Aug 14, 2026
EPS / ์˜ˆ์ƒ
-5.31/-6.02
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
36.79%-5.31
92.71%-6.41
99.96%-6.23
88.78%-40.13
99.32%-8.40
98.81%-87.87
-92.90%-16.92K
97.82%-357.85
96.90%-1.24K
-157.27%-7.36K
68.97%-8.77K
---16.40K
---39.92K
--12.86K
---28.26K
--4.11K
----
----
----
----
์ˆ˜์ต
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
28.62%3.11M
54.45%3.67M
111.62%3.10M
์ˆœ์ด์ต
-2.45%-6.36M
-6.02%-6.79M
6.56%-5.90M
-76.98%-9.03M
-5.46%-6.20M
6.23%-6.41M
-6.93%-6.31M
19.47%-5.10M
25.98%-5.88M
-346.45%-6.83M
-27.17%-5.90M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
25.99%-4.64M
-9.25%-7.64M
453.13%28.01M
-6.08%-7.70M
11.07%-6.27M
-3.03%-7.00M
์ˆœ์ด์ต๋ฅ 
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--391.04%
----
----
----
----
์ด ์ด์ต๋ฅ 
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--100.00%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--0.00%
--0.00%
--10.10%
--12.34%
----
----
----
----
์ˆ˜์ต
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
28.62%3.11M
54.45%3.67M
111.62%3.10M
์˜์—… ์ด์ต
-3.49%-6.44M
-5.51%-6.84M
6.05%-6.00M
-45.98%-7.61M
-3.35%-6.23M
7.20%-6.48M
0.03%-6.38M
20.55%-5.21M
26.34%-6.02M
9.97%-6.98M
-23.15%-6.38M
15.71%-6.56M
-8.15%-8.18M
-38.23%-7.76M
-28.32%-5.18M
-63.87%-7.78M
-32.16%-7.56M
18.54%-5.61M
40.75%-4.04M
23.95%-4.75M
์ˆœ์ด์ต
-2.45%-6.36M
-6.02%-6.79M
6.56%-5.90M
-76.98%-9.03M
-5.46%-6.20M
6.23%-6.41M
-6.93%-6.31M
19.47%-5.10M
25.98%-5.88M
-346.45%-6.83M
-27.17%-5.90M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
25.99%-4.64M
-9.25%-7.64M
453.13%28.01M
-6.08%-7.70M
11.07%-6.27M
-3.03%-7.00M
์œ ๋™์ž์‚ฐ
-2.55%10.80M
343.14%15.98M
116.54%23.08M
126.22%22.65M
15.68%11.08M
-70.13%3.61M
-44.09%10.66M
-52.61%10.01M
-57.76%9.58M
-57.61%12.07M
-30.54%19.07M
-14.18%21.13M
-27.77%22.68M
-31.64%28.48M
-47.78%27.45M
-58.18%24.62M
-52.25%31.40M
-33.70%41.67M
11.23%52.57M
92.06%58.87M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
6.07%5.19M
-11.74%4.76M
-2.53%6.05M
-4.56%5.61M
-9.74%4.89M
-14.37%5.39M
-14.08%6.21M
-13.96%5.88M
-21.59%5.42M
8.64%6.30M
-17.02%7.22M
-12.20%6.84M
-1.31%6.91M
-75.70%5.80M
-74.95%8.71M
-75.95%7.79M
-77.31%7.00M
-18.70%23.86M
139.06%34.76M
336.56%32.38M
์ด ์ž์‚ฐ
-7.07%14.52M
138.58%19.90M
74.42%27.19M
78.24%27.00M
4.71%15.62M
-52.68%8.34M
-37.24%15.59M
-44.17%15.15M
-48.39%14.92M
-49.59%17.63M
-27.39%24.84M
-14.41%27.13M
-25.48%28.91M
-22.61%34.97M
-39.55%34.22M
-50.48%31.70M
-45.72%38.80M
-34.28%45.18M
5.70%56.60M
71.04%64.00M
๋ถ€์ฑ„ ์ด๊ณ„
-6.84%8.48M
-15.54%8.29M
-9.44%9.81M
-10.46%9.60M
-12.99%9.10M
-14.84%9.81M
-14.14%10.84M
-13.58%10.73M
-17.39%10.46M
-1.60%11.53M
-22.29%12.62M
-22.11%12.41M
-19.64%12.66M
-77.06%11.71M
-70.68%16.24M
-71.91%15.93M
-72.65%15.75M
-12.33%51.07M
49.88%55.38M
61.03%56.71M
์ž๋ณธ ์ด๊ณ„
-7.40%6.04M
888.32%11.61M
265.53%17.38M
293.48%17.39M
46.18%6.52M
-124.14%-1.47M
-61.09%4.75M
-69.97%4.42M
-72.54%4.46M
-73.76%6.10M
-32.01%12.22M
-6.62%14.72M
-29.48%16.25M
495.24%23.26M
1378.13%17.97M
116.15%15.76M
66.03%23.05M
-156.02%-5.88M
-92.67%1.22M
231.15%7.29M
์ˆœ์˜์—…์ด์ต
23.11%-5.45M
-21.14%-7.96M
9.08%-5.24M
-28.07%-6.69M
-15.28%-7.09M
1.14%-6.58M
-9.63%-5.76M
16.31%-5.22M
-28.11%-6.15M
-245.66%-6.65M
11.55%-5.25M
9.51%-6.24M
-56.45%-4.80M
189.23%4.57M
-53.07%-5.94M
-31.55%-6.90M
39.24%-3.07M
31.81%-5.12M
36.63%-3.88M
29.04%-5.24M
์ˆœํˆฌ์ž
--0.00
--0.00
----
----
----
----
--0.00
----
--0.00
--0.00
--0.00
100.00%0.00
100.00%0.00
--0.00
100.00%0.00
69.23%-4.00K
93.61%-25.00K
100.00%0.00
-34.09%-118.00K
---13.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
-94.95%726.00K
--871.00K
-13.78%5.79M
273.58%18.34M
261.90%14.36M
100.00%0.00
120.62%6.72M
13.01%4.91M
725.16%3.97M
99.84%-3.00K
-49.22%3.05M
968.80%4.34M
115.14%481.00K
62.05%-1.87M
294.99%6.00M
83.45%-500.00K
-138.22%-3.18M
-120.62%-4.94M
-114.48%-3.08M
-112.22%-3.02M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Aptevo Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 23.08M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 116.54์ž…๋‹ˆ๋‹ค.

Aptevo Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aptevo Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 27.19M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 74.42์ž…๋‹ˆ๋‹ค.

Aptevo Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aptevo Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 9.81M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -9.44์ž…๋‹ˆ๋‹ค.

Aptevo Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aptevo Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 17.38M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 265.53์ž…๋‹ˆ๋‹ค.

Aptevo Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aptevo Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -26.31M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -6.95์ž…๋‹ˆ๋‹ค.

Aptevo Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Aptevo Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 38.50M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 146.85์ž…๋‹ˆ๋‹ค.

Aptevo Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -87.27์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 99.99์ž…๋‹ˆ๋‹ค.

Aptevo Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -27.54M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -14.12์ž…๋‹ˆ๋‹ค.

Aptevo Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -248.81์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 12.48์ž…๋‹ˆ๋‹ค.

Aptevo Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -121.38์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -1.70์ž…๋‹ˆ๋‹ค.

Aptevo Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Aptevo Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -26.31M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -6.95์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ